Saidal issued the following announcement on July 9.
The Ministry of Health, Population and Hospital Reform has just granted the SAIDAL Group the authorization to operate its Bioequivalence Center.
The center is the first of its kind in Algeria, its mission is to conduct bioequivalence studies on several types of generic drugs produced by SAIDAL and other laboratories, its activities will help to strengthen the quality of the group’s products nationwide. and international and thereby enable it to seize export opportunities.
Original source: http://saidalgroup.dz/fr/actualites/item/1565-centre-de-bioequivalence-du-groupe-saidal
